Increased oxidative stress in hemodialysis patients with high risk for sleep apnea syndrome

Blood Purification

Volumn 28, Issue 2, 2009, Pages 144-149

  Lim, Paik Seong ^a,b   Chen, Wen Ching ^c,d   Wu, Ming Ying ^a   Hu, Chuen Yuh ^a   Chien, Po I ^c  

^a TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^b PROVIDENCE UNIVERSITY   (Taiwan)

^c Kang Ming Clinic   (Taiwan)

^d NONE   (Taiwan)

Author keywords

Hemodialysis; Oxidative stress; Sleep apnea syndrome

Indexed keywords

3 NITROTYROSINE; ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM; CD40 LIGAND; CHOLESTEROL; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; OXYGEN RADICAL; PHOSPHORUS; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; HYPOXIA; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; SLEEP APNEA SYNDROME; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ENDOTHELIUM;

AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS; RISK FACTORS; SLEEP APNEA SYNDROMES;

EID: 67649850339     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000227283     Document Type: Article

References (47)

1. Becker LB: New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 2004;61:461-470. (Pubitemid 38210152)
2. Wolk R, Kara T, Somers VK: Sleep-disordered breathing and cardiovascular disease. Circulation 2003;108:9-12.
3. Liu SX, Hou FF, Guo ZJ, Nagai R, Zhang WR, Liu ZO, Zhou ZM, Zhou M, Xie D, Wang GB, Zhang X: Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol 2006;26:1156-1162. (Pubitemid 43732127)
4. Svatikova A, Wolk R, Lerman LO, Juncos LA, Greene EL, McConnell JP, Somers VK: Oxidative stress in obstructive sleep apnoea. Eur Heart J 2005;26:2435-2439. (Pubitemid 41552973)
5. Lavie L, Vishnevsky A, Lavie P: Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004;27:123-128. (Pubitemid 43906323)
6. Yamauchi M, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Suzuki T, Kimura H: Oxidative stress in obstructive sleep apnea. Chest 2005;127:1674-1679. (Pubitemid 46218794)
7. Suzuki YJ, Jain V, Park AM, Day RM: Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases Free Radic Biol Med 2006;40:1683-1692.
8. Christou K, Moulas AN, Pastaka C, Gourgoulianis KI: Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 2003;4:225-228. (Pubitemid 36748608)
9. Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, Klag MJ: Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE study. J Am Soc Nephrol 2002;13:1918-1927. (Pubitemid 34700618)
10. Zoccali C: Cardiovascular risk in uraemic patients: is it fully explained by classical risk factors? Nephrol Dial Transplant 2000;15:454-457.
11. Himmelfarb J, McMonagle E: Manifestations of oxidant stress in uremia. Blood Purif 2001;19:200-205.
12. Argekar P, Griffin V, Litaker D, Rahman M: Sleep apnea in hemodialysis patients: risk factors and effect on survival. Hemodial Int 2007;11:435-441. (Pubitemid 47534869)
13. Jung HH, Han H, Lee JH: Sleep apnea, coronary artery disease, and antioxidant status in hemodialysis patients. Am J Kidney Dis 2005;45:875-882. (Pubitemid 43181047)
14. Chen WC, Lim PS, Wu WC, Chiu HC, Chen CH, Kuo HY, Tsai TW, Chien PI, Su YJ, Su YL, Hung SH, Woods HF: Sleep behavior disorders in a large cohort of Chinese (Taiwanese) patients maintained by long-term hemodialysis. Am J Kidney Dis 2006;48:277-284.
15. Merlino G, Piani A, Dolso P, Adorati M, Cancelli I, Valente M, Gigli GL: Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy. Nephrol Dial Transplant. 2006 21:184-190. (Pubitemid 43057128)
16. Kuhlmann U, Becker HF, Birkhahn M, Peter JH, von Wichert P, Schutterle S, Lange H: Sleep-apnea in patients with end-stage renal disease and objective results. Clin Nephrol 2000;53:460-466. (Pubitemid 30390076)
17. Jurado-Gamez B, Martin-Malo A, Alvarez-Lara MA, Muñoz L, Cosano A, Aljama P: Sleep disorders are underdiagnosed in patients on maintenance hemodialysis. Nephron Clin Pract 2007;105:c35-c42. (Pubitemid 46006570)
18. Chan CT: Sleep apnea with intermittent hemodialysis: time for a wake-up call! J Am Soc Nephrol 2006;17:3279-3280.
19. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP: Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999;131:485-491. (Pubitemid 29482391)
20. Ter Steege JCA, Koster-Kamphuis L, Van Straaten E, Forget P, Buurman WA: Nitrotyrosine in plasma of celiac disease patients as detected by a new sandwich ELISA. Free Radical Biol Med 1998;25:953-963. (Pubitemid 28538562)
21. Reznick AZ, Packer L: Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994;233:357-363. (Pubitemid 24177561)
22. Wong SH, Knight JA, Hopfer SM, Zaharia O, Leach CN Jr, Sunderman FW Jr: Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 1987;33:214-220. (Pubitemid 17161121)
23. Ip MS, Lam B, Lauder IJ, Tsang KW, Chung KF, Mok YW, Lam WK: A community study of sleep-disordered breathing in middle-aged Chinese men in Hong Kong. Chest 2001;119:62-69. (Pubitemid 32150548)
24. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235. (Pubitemid 23115702)
25. Phillipson EA: Sleep apnea: a major public health problem. N Engl J Med 1993;328:1271-1273. (Pubitemid 23115709)
26. Stepanski E, Faber M, Zorick F, et al: Sleep disorders in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1995;6:192-197.
27. Fletcher EC: Obstructive sleep apnea and the kidney. J Am Soc Nephrol 1993;4:1111-1121.
28. Unruh ML, Hartunian MG, Chapman MM, Jaber BL: Sleep quality and clinical correlates in patients on maintenance dialysis. Clin Nephrol 2003;59:280-288. (Pubitemid 36503547)
29. Zoccali C, Mallamaci F, Tripepi G: Sleep apnea in renal patients. J Am Soc Nephrol 2001;12:2854-2859.
30. Shamsuzzaman AS, Gersh BJ, Somers VK: Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003;290:1906-1914. (Pubitemid 37430608)
31. Schafer H, Koehler U, Ewig S, Hasper E, Tasci S, Luderitz B: Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 1999;92:79-84. (Pubitemid 30135935)
32. Dyken ME, Somers VK, Yamada T, Ren ZY, Zimmerman MB: Investigating the relationship between stroke and obstructive sleep apnea. Stroke 1996;27:401-407. (Pubitemid 26081432)
33. Yamauchi M, Kimura H: Oxidative stress in obstructive sleep apnea: putative pathways to the cardiovascular complications. Antioxid Redox Signal 2008;10:755-768. (Pubitemid 351225902)
34. Campen MJ, Shimoda LA, O'Donnell CP: Acute and chronic cardiovascular effects of intermittent hypoxia in C57BL/6J mice. J Appl Physiol 2005;99:2028-2035. (Pubitemid 41547206)
35. Joyeux-Faure M, Stanke-Labesque F, Lefebvre B, Beguin P, Godin-Ribuot D, Ribuot C, Launois SH, Bessard G, Levy P: Chronic intermittent hypoxia increases infarction in the isolated rat heart. J Appl Physiol 2005;98:1691-1696. (Pubitemid 40570778)
36. Zhan G, Serrano F, Fenik P, Hsu R, Kong L, Pratico D, Klann E, Veasey SC: NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med 2005;172:921-929. (Pubitemid 41369078)
37. Ryan S, Taylor CT, McNicholas WT: Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005;112:2660-2667. (Pubitemid 41532603)
38. Peng YJ, Yuan G, Ramakrishnan D, Sharma SD, Bosch-Marce M, Kumar GK, Semenza GL, Prabhakar NR: Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol 2006;577:705-716. (Pubitemid 44804021)
39. Gjorup PH, Sadauskiene L, Wessels J, Nyvad O, Strunge B, Pedersen EB: Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens 2007;20:44-52. (Pubitemid 46014056)
40. Ohga E, Nagase T, Tomita T, Teramoto S, Matsuse T, Katayama H, Ouchi Y: Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 1999;87:10-14. (Pubitemid 29330658)
41. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, Adachi M: Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107:1129-1134. (Pubitemid 36297204)
42. Lutgens E, Daemen MJAP: CD40-CD40L interactions in atherosclerosis. Trends Cardiovasc Med 2002;12:27-32.
43. Schönbeck U, Libby P: CD40 signaling and plaque instability. Circ Res 2001;89:1092-1103.
44. Boaz M, Matas Z, Biro A, Katzir Z, Green M, Fainaru M, Smetana S: Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis. Kidney Int 1999;56:1078-1083. (Pubitemid 29411736)
45. 2α as a useful clinical biomarker of oxidative stress in ESRD patients. Blood Purif 2002;20:537-542.
46. Tetta C, Biasioli S, Schiavon R, Inguaggiato P, David S, Panichid V, Wratten ML: An overview of haemodialysis and oxidant stress. Blood Purif 1999;17:118-126.
47. Taki K, Takayama F, Tsuruta Y, Niwa T: Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients. Kidney Int 2006;70:218-224. (Pubitemid 44000142)